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SUMMARY 
Bisphenol A (BPA) is one of the most produced chemicals in the industry today, and humans 
are exposed to it every day. BPA has a week oestrogen-like effect and binds to different 
receptors in the body. One of these is the androgen receptor (AR) that has an important role in 
the follicular development in the ovary. The aim of this study was to examine the ovaries of 
rats exposed to low dose BPA during embryonic and foetal stage and neonatal period and to 
examine the androgen receptor expression and the number of primary and secondary follicles 
in 52 weeks old rats.   
 
Pregnant rats were exposed to two different doses of BPA (0.5 or 50 g/kg/day) in the drinking 
water, from gestation day 3.5 to postnatal day 22. The pups were therefore exposed in utero 
and via lactation and were then kept unexposed to BPA for 52 weeks. The ovaries were then 
prepared for immunohistochemistry and the AR was stained. The primary and secondary 
follicles were counted, and the AR expressions in the secondary and antral follicles were 
evaluated. 
 
No significant differences were found between the BPA dosage groups and the negative control, 
which may indicate that BPA does not interfere with either the follicle assembly or the AR 
expression in the follicles. However, it has previously been observed that the same ovaries had 
a higher weight after BPA treatment, and the reason for this is still not explained. Since BPA is 
a chemical constantly present in our everyday life, more studies have to be made in order to 
answer the question if low doses of BPA affect the ovary. 
 
 
 
 
  
  
SAMMANFATTNING 
Bisfenol A (BPA) är en av världens mest producerade kemikalier och människor exponeras för 
den dagligen. BPA är en kemikalie med en svag östrogenliknande effekt och binder till olika 
receptorer i kroppen. En av dessa är androgenreceptorn (AR) som är viktig i utvecklingen av 
folliklar i ovariet. Syftet med den här studien var att undersöka ovarier från 52 veckor gamla 
råttor, som har varit exponerade för låga doser av BPA under embryo- och fosterstadiet samt 
neonatalperioden, och utreda om det har blivit någon skillnad i AR-uttrycket och antalet 
primära och sekundära folliklar.  
 
Dräktiga råttor exponerades för BPA i två olika doser (0,5 eller 50 g/kg/d) via dricksvattnet, 
från dräktighetsdag 3,5 till postnatal dag 22. Råttungarna exponerades alltså för BPA in utero 
och via laktation. Råttorna hölls därefter oexponerade för BPA tills de var 52 veckor. Ovarierna 
preparerades för immunohistokemi och AR färgades in. Primära och sekundära folliklar 
räknades och uttrycket av AR utvärderades i sekundära och antrala folliklar.  
 
Inga signifikanta skillnader kunde påvisas mellan grupperna som hade blivit behandlade med 
BPA och kontrollgruppen. Detta tyder på att BPA inte påverkar antalet folliklar och inte heller 
AR-uttrycket. Däremot har tidigare studie av samma ovarier visat att de exponerade ovarierna 
hade en högre vikt jämfört med kontrollgruppen, men orsaken till denna viktökning är 
fortfarande inte förklarad. Eftersom BPA är en kemikalie som finns i vår vardag och som vi 
ständigt exponeras för, behövs fler studier för att undersöka om låga doser av BPA påverkar 
ovariet.  
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INTRODUCTION 
Bisphenol A (BPA) is a synthetic oestrogen-like chemical and was known to affect the female 
reproductive system in rats as early as in 1936 (Dodds 1936: see Rochester 2013). BPA is 
globally one of the most produced industry chemicals and is used mainly in production of 
polycarbonate- and epoxy plastics (Beronius & Hanberg, 2011; Plastics Europe, 2017). Humans 
are exposed to BPA for example via food cans, beverage bottles, indoor dust, CD- and DVD 
discs, electronic equipment, thermal paper (used in recipes and tickets). All these merchandise 
and many other consumer products are used on a daily basis (Rudel et al., 2003; Beronius & 
Hanberg, 2011) and the chemical is frequently detected in human blood and urine (reviewed in 
Vandenberg et al., 2007).  
 
BPA is an endocrine-disrupting chemical (EDC) since it has been proved to bind different 
receptors like the androgen-, oestrogen- and thyroid receptor and can for example inhibit or 
activate gene transcription depending on which receptor it binds to (Moriyama et al., 2002; 
Teng et al., 2013). The androgen receptor is expressed in the ovary and is proven to be important 
for the follicular development (Walters & Handelsman, 2017). BPA is an antagonist to the 
androgen receptor (Teng et al., 2013), and animals exposed to BPA have previously been shown 
to cause an alteration in the expression of the androgen receptor in the ovary (Rivera et al., 
2015; Santamaria et al., 2016). 
 
In Sweden, BPA is prohibited in food packages to children under three years of age and in the 
EU in baby bottles, and it will be banned in thermal paper in 2020. In January 2017 BPA was 
added to the Candidate List of ECHA (European Chemicals Agency) among other “Chemicals 
of Concern” that are estimated to be particularly serious and hazardous with a persistent and 
prolonged effect on the environment or the human health (The Swedish Chemicals Agency, 
2016; EFSA, 2017). Epidemiological studies in humans have reported associations between 
exposure to BPA and many different diseases including; cardiovascular disease, type-2 
diabetes, obesity, altered immune function, disturbed neurodevelopment in children, asthma 
and infertility in humans (reviewed in Rochester, 2013). 
 
In 2015, the European Food Safety Authority (EFSA) lowered the tolerable daily intake (TDI) 
of BPA in food from 50 to 4 g/kg/day and estimated the highest daily exposure of BPA to 
humans to be 1.5 g/kg (EFSA CEF Panel, 2015). The discussion today is if BPA is hazardous 
in even lower doses than earlier acknowledged since it is possible that BPA is following a non-
monotonic dose-response curve. Given that, there is a risk that BPA can affect humans in lower 
doses than the present TDI (Welshons et al., 2006; Vandenberg et al., 2012).  
 
Ekoutsidou (2017) found, in her master thesis, that rats exposed to 50 g BPA/kg/day, but not 
0.5 g BPA/kg/day, during embryonic and foetal stage and neonatal period had ovaries with 
increased weight compared to negative control. No difference was found regarding to the 
number of antral follicles, atretic follicles or corpora lutea (CL) that could explain the higher 
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weight. To continue the study of the same ovaries, the aim was to examine the androgen 
receptor expression and the number of primary and secondary follicles in 52 weeks old rats.   
 
LITERATURE REVIEW 
Endocrine-disrupting chemicals 
The endocrine system is regulated by extremely low doses of hormones that act as ligands and 
binds to different receptors in order to, for example alter gene expression (Vandenberg et al. 
2012). EDCs are described as exogenous chemicals that interfere with any part of the endocrine 
system and the hormone action (Zoeller et al., 2012) and thereby influence the metabolism, the 
production and the uptake or release of hormones. Thus, EDCs may have important biological 
consequences (Zoeller et al., 2012; Vandenberg et al., 2013). Vandenberg et al. (2012) discuss 
in their review that EDCs have different effects in different doses; that low doses are 
physiological and may affect some endpoints, compared to high doses that are described as 
toxic.  
 
Exposure to BPA in the uterus 
Embryos and foetuses are in the early development almost completely protected from maternal 
oestrogen by a plasma protein, produced in the foetal liver, called -fetoprotein (Gitlin et al., 
1972; Montano et al., 1995). However, -fetoprotein does not protect the foetus from some of 
the EDCs, because they bind inadequately to the protein, and may therefore harm the foetus 
during the sensitive phases of development. BPA is one of those EDCs, and has been reported 
to bind weakly to -fetoprotein from rat amniotic fluid compared to oestradiol (Milligan et al., 
1998; Vandenberg 2012).  
 
It has also been shown that BPA binds to the oestrogen-related receptor  that is highly 
expressed in the placenta (Okada et al., 2008; Poidatz et al., 2012), which may result in an 
accumulation of BPA in the placenta and therefore increase the exposure of the developing 
foetus (Teng et al., 2013).  
Development and the endocrine system of the rat ovary  
The rat ovaries develop from the gonadal ridges and at embryonic day 13, they contain 
primordial germ cells. At day 16–19 all the oocytes within the ovaries develop and enters the 
prophase of the first meiotic division. At birth, the oocytes are still embedded within the 
epithelium covering the ovary. The formation of primary follicles occurs in response to follicle-
stimulating hormone (FSH) and luteinizing hormone (LH) during the second week of postnatal 
development (Hebel & Stromberg, 1986; Erb, 2006). Thus, the total follicular differentiation in 
rodents does not occur pre partum in contrast to humans and sheep (Rivera et al., 2015). During 
the rat pups first week, the ovary begins to convert small amounts of oestradiol 12 from the 
androgen testosterone in response to FSH. Between 3 and 4.5 weeks of age, the ovary goes 
through a transition, but only if the ovary receives proper hormonal stimulation and the follicles 
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become capable of oestrogen secretion (Lohmiller & Swing, 2006). Depending on when the 
mammals are exposed to different toxins, the organs will express different alterations and it is 
therefore important to define the critical periods of development (Vandenberg et al., 2012).  
 
The weight of the ovary after exposure to BPA 
In a study by Santamaria et al. (2016) the rats were exposed to low dose of BPA (0.5 and 50 
g/kg/day), during early development, from gestation day 9 (GD9) to postnatal day 21 (PND21) 
and sacrificed at PND90. They found that the ovaries had a lower weight after BPA exposure. 
This is contrary to what Ekoutsidou (2017) found in her master thesis, where the rats were 
exposed to the same doses of BPA, but the ovaries from the rats exposed to 50 g/kg/day had 
a higher weight compared to the control group. Interestingly, the difference in exposure 
between the two studies is that the rats that had lower ovary weights were exposed from GD9 
and the rats that had higher ovary weights were exposed a few days earlier, from GD3.5. 
However, Santamaria et al. (2016) only presented data from 8 rats in each group, although it 
was earlier stated to be 10–12 rats in each group with no explanation why not all ovaries were 
weighed or presented.  
 
Kobayashi et al. (2012) published an article with the conclusion that BPA did not cause any 
important effects when rats were exposed to 50, 500 and 5000 g BPA/kg/day in the diet from 
GD6 to PND21. However, at 5 weeks the female offspring had exposed in utero and by 
lactation, a significantly higher relative ovary weight after exposure to high doses of BPA (500 
and 5000 g/kg/day). Unfortunately, the ovaries were not examined morphologically and the 
higher weight could not be explained. Also, no significant alteration was registered compared 
to control when the ovaries were weighed at 3 months. However, the group have not stated any 
extra precautions to minimize environmental BPA exposure nor were the food consumption 
measured which makes it impossible to know the exact BPA dose.  
 
A large three-generation rat study by Tyl et al. (2002), sponsored by the plastic industry and 
influential in the EFSA evaluation on BPA (EFSA CEF Panel, 2015), with oral dosage regime 
from 1g/kg/day to 500 mg/kg/day concluded that BPA is not toxic for reproductive organs in 
low doses (Tyl et al., 2002). Although, when examining the statistics, the relative paired ovary 
weights were significantly reduced in the F2 generation exposed to BPA (from embryonic life 
until weaning and during gestation and lactation) in doses of 1 and 300 g/kg/day, 5 mg/kg/day 
and 500 mg/kg/day. Disturbingly, these findings are not commented in the result or discussion 
section. Only the 500 mg/kg/day dosage regime, which gave lower ovary weight in all the 
generations where presented and discussed. They also claim that no significant 
histopathological findings could be observed in the ovaries, but it appears as if they were only 
registering atrophy and follicle cysts. It also seems like they counted the primordial follicles in 
the ovaries from the 500 mg/kg/day dosage group and the negative control group (and did not 
find any differences), but overlooked the other dosage regimes. vom Saal & Welshons (2006) 
are very critical to the Tyl et al. (2002) study in their review, pointing out that the rat model 
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that was used is less sensitive to oestrogens and that the rats were given an animal feed with 
high phytoestrogenic content. Also, as in many other BPA studies, Tyl et al (2002) are lacking 
a positive control. vom Saal & Welshons (2006) discuss in their review the importance to have 
a positive control when studying toxicology, for example in BPA experiments, especially when 
interpreting negative results. They claim that the purpose with a positive control is to 
demonstrate the positive effects that are being measured and to prove that the assay used is 
sensitive to the class of chemical that are examined. Also, if the test chemical only produces 
negative results, it can be compared and stated to be significantly different from the positive 
control.  
Androgen receptor in the ovary  
The AR is expressed in the ovarian stroma, most of the ovarian follicle stages and in the CL, 
which indicates that AR-mediated actions play a specific role in the development of the 
follicles. In the rat, the AR has also been located in the granulosa and theca cells and in the 
oocyte of preantral follicles (Walters & Handelsman, 2017). The AR has also shown to be 
important in the regulation of follicular growth and atresia by two different pathways in 
granulosa cells, which are central in the regulation of normal ovary function (Sen et al. 2014). 
It has also been demonstrated that upon activation of the AR, the FSH receptor expression 
increases. This will in turn induce an increased sensitivity to FSH leading to follicular growth 
(Sen et al. 2014). An AR knockout mouse strain with inactivated AR, gradually develops an 
increasing number of atretic follicles and is completely infertile by 40 weeks of age with no 
follicles in the ovary, demonstrating the importance of AR-signalling within the ovary (Shiina 
et al., 2006). 
 
BPA and the androgen receptor 
BPA is an anti-androgen and binds competitively to the AR. It appears as if BPA does not 
promote any function of the AR, but unlike any other known antagonists it prevents the efficient 
nuclear translocation of AR (Teng et al., 2013). This may result in that AR requires a higher 
concentration of an agonist for activation or need a longer time for the translocation process 
(Teng et al., 2013). BPA has also been shown to act as an anti-androgen by inhibiting some 
regions in the receptor and down-regulate the AR signalling in other domains (Wang et al., 
2017).  
 
BPA effects on the androgen receptor in the ovary  
Rats exposed orally to BPA 
Santamaria et al. (2016) found in their study, in addition to lower ovary weight, that BPA 
treated animals had an increased amount of CL at PND90, a finding they interpreted as 
superovulation due to BPA exposure. Also, blood samples were drawn from the rats, which 
showed a higher level of progesterone among animals treated with BPA. AR and oestrogen 
receptor  (ER) expression in the ovaries were evaluated to gain information on which way 
BPA may alter the follicular development and ovulation. The expression of ER was 
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unchanged when BPA treated animals were compared to the control group. However, the rats 
treated with 50 g/kg/day had a reduced expression of AR in primary-, preantral- and antral 
follicles and the rats treated with 0.5 g/kg/day had a reduced expression of AR in the primary 
follicles and increased expression in the primordial follicles compared to negative control. They 
also found an increased expression of the FSH receptor in the ovaries from rats treated with 0.5 
g/kg/day. Santamaria et al. (2016) interprets their results as that BPA affects the ovaries ability 
to ovulate through different mechanisms when exposed to different dosages.  
 
Santamaria et al. (2016) presents in their supplementary data that the rats were exposed to a 
higher dose BPA than what the study design aimed for, the 0.5 g/kg/day group actually got 
about 0.7 g/kg/day, and the 50 g/kg/day group got about 64 g/kg/day. Ekoutsidou (2017) 
also presented the average oral doses, showing that the 0.5 g/kg/day group got 0.4 g/kg/day 
and the 50 g/kg/d got 40 g/kg/day. However, the doses were calculated continuously during 
the total exposure time and this revealed that the rats got a lot higher dose after parturition than 
during gestation. The higher dose can be explained by higher water consumption when lactating 
than during gestation and since the BPA was supplemented through the water, the rats got a 
higher dose when drinking more (Ekoutsidou, 2017).  
 
Rats exposed subcutaneously to BPA 
To control the exact dose the rats were exposed to, Rodríguez et al. (2010) injected 20 mg 
BPA/kg/day or 50 g BPA/kg/day subcutaneous on PND1, 3, 5 and 7. At PND8 the pups were 
sacrificed and the ovaries were studied. Rats exposed to 20 mg BPA/kg/day had a decrease in 
primordial follicles and an increase in primary follicles compared to negative control. These 
changes could not be found in the 50 g/kg/day group. They also studied the expression of 
steroid receptors, and found AR mostly located in granulosa, theca and stroma cells with the 
highest levels in the preantral follicles. However, contrary to Santamaria et al. (2016), the AR 
expression was not significantly altered by the exposure of BPA. 
 
The route of administration of BPA in experimental designs has been discussed thoroughly by 
different scientists and reviewed in many articles. Since the major route of exposure in humans 
is through the diet, many consider oral exposure to be the only proper design in animal 
experiments to be able to extrapolate the results to humans (Richter et al., 2007; Hengstler et 
al., 2011; Beronius & Hanberg, 2012; Thigpen et al., 2013). If the same dose is given through 
subcutaneous administration, it will avoid the first pass hepatic metabolism and the circulating 
BPA is therefore likely to end up in higher levels and with more bioactivity than via oral route 
(Pottenger et al., 2000).  
 
Lambs exposed to subcutaneous BPA 
In a study by Rivera et al. (2015), they injected 0.5 g BPA/kg/day and 50 g BPA/kg/day 
subcutaneously in young lambs from birth to PND30 and examined the ovaries. As a positive 
control they used diethylstilbestrol (DES), which also is a synthetic oestrogen but it has much 
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stronger bioactivity than endogenous oestradiol (McLachlan et al., 1984: see Rivera et al. 
2015). Some of the lambs were also given FSH in multiple doses for two days after PND 30, to 
demonstrate the response of the ovaries and to detect dysfunctions in the growing follicles. 
Rivera et al. (2015) showed that early postnatal BPA exposure to lambs led to decreased 
follicular development with lower number of follicles and lower oestradiol production, 
compared to negative control, which were interpreted as inability of the ovaries to respond to 
FSH treatment after BPA exposure. They also studied the expression of steroid receptors in the 
ovary. There were no changes in the ER levels, but the AR level was altered after BPA exposure 
in both doses. The small antral follicles had a lower AR expression after treated with FSH 
compared to the negative control. The authors interpreted the lower AR protein result after BPA 
exposure as an explanation to the depressed follicular development (Rivera et al., 2015).  
 
Although the authors were able to control the exact dose of BPA and DES, they did not control 
the environmental oestrogen-like compounds that the animals were exposed to. For example, 
the mother ewes were held at pasture with low amount of clover, and the exact amount of the 
phytoestrogens were not evaluated. Neither were any specific assurances made for minimum 
exposure of BPA from the environment, for example the water system. This is unfortunate since 
the negative control is supposed to be totally negative and all the results are interpreted as a 
change from the negative control. Also, the study does not appear to have been blinded, which 
is unfortunate, especially since the immunostaining was evaluated in a graded scale and not by 
quantified measurement, resulting in possible bias.   
 
Rivera et al. (2011) studied ovaries from lambs exposed to 50 g BPA/kg/day subcutaneously 
from PND1 to PND14. They found fewer primordial follicles and an increase of transitional 
and primary follicles at PND30 after BPA treatment. Rivera et al. (2011) also studied the steroid 
receptor expression, but contrary to later findings by Rivera et al. (2015) and Santamaria et al. 
(2016) they did not find any alteration in the expression of AR or ER comparing BPA exposed 
lambs to negative control, nor were the oestrogen or testosterone serum levels affected. 
  
Summary  
The articles presented demonstrate different results, were animals of different species were 
exposed during different time periods and routes and examined at different ages. High doses of 
BPA have been reported to have toxic effects on the ovary (Tyl et al. 2002; Kobayashi et al. 
2012; Delclos et al. 2014), but it is still unclear if and in what way low doses of BPA affect the 
ovary.  
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MATERIAL AND METHODS 
The rats were housed and exposed to BPA at an Uppsala University animal facility, Sweden, 
with the overall aim to investigate effects of BPA on bone and adipose tissue. For details, see 
Lejonklou et al. (2017). Scientists from the Department of Clinical Sciences, Division of 
Reproduction in Swedish University of Agricultural Sciences, collected the ovaries from these 
rats.  
 
Chemicals 
Bisphenol A, (CH3)2C(C6H4OH)2 (≥99% purity, CAS 80-05-7, Sigma Aldrich) was dissolved 
in tap water and ethanol (1% of final solution) to defined concentrations.  
 
Animals 
The study was approved by the Uppsala Ethical Committee on Animal Research (C26/13), 
following guidelines by the European Union Legislation (Convention ETS123 and Directive 
2010/63/EU).  
 
Forty-five 9 weeks old pregnant female Fischer (F344/DuCrl) rats were housed individually in 
enriched polysulfone cages (Euro Standard IV) with glass water bottles, to avoid background 
BPA exposure. Feed and water intake were registered and available ad libitum. The diet was 
analysed by the manufacturer and the content of phytoestrogens were below the Organisation 
for Economic Co-operation and Development’s (OECD’s) upper limit.  
 
Exposure  
The pregnant rats were divided into three dosage groups randomly, lower dose: 0.5 g 
BPA/kg/day (n=12), higher dose 50 g BPA/kg/day (n=15) and control (water with 1% of 
ethanol) (n=17).  The dams were exposed per os via drinking water from GD3.5 to PND22. 
Thus, the pups were exposed via in utero and via lactation. The water consumption was 
measured and the actual individual exposure was calculated (supplemental table 2, Lejonklou 
et al. 2017).  
 
At PND4 the litters were adjusted to 3 males and 3 females per dam and on PND22 the dams 
were sacrificed. The pups were moved to a new cage with three offspring from different 
mothers to avoid litter effects, but with same sex and exposure group. Altogether, there were 
27 female offspring whereof 11 controls, 8 in the 0.5 g BPA/kg/day group and 8 in the 50 g 
BPA/kg/day group. The rats were sacrificed at 52 weeks of age at dioestrus and the ovaries 
were collected, although one of the control rats was found to be in oestrus and was therefore 
excluded. The ovaries were weighed and fixed in 4% buffered formalin.  
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Immunohistochemistry 
The left ovary was then embedded in paraffin and the ovaries were sectioned in series 8 m 
thick. 4-6 sections from every ovary were put on one slide each. Three different middle sections 
of each ovary were used to count primary and secondary follicles and to evaluate AR 
expression. 
 
The immunohistochemistry procedure was run once for testing different dilutions of the 
primary antibody and to optimize the test. First, deparaffinization was performed with the slides 
washed in xylene and ethanol. Then, antigen retrieval was done with citrate buffer in 95 °C 
water bath for 25 minutes. The slides were put first in hydrogen peroxide (1–1.5%) and then in 
5% serum (Normal Goat Serum, ab7481, Abcam, Cambridge, UK) for blocking. Primary 
antibody was added to the slides: Anti-Androgen Receptor Antibody IHC-plus™ LS-B8656, 
Rabbit Polyclonal (IgG), 0.2 mg/ml LSBio (LifeSpan BioSciences, Inc. Seattle, WA), with a 
dilution of 1:40–1:55 for 1 hour and 45 minutes at room temperature. The secondary antibody 
(Goat Anti–Rabbit IgG H&L (HRP), ab205718, Abcam, 500 g at 2 mg/ml), with a dilution of 
1:2000 was added to the slides and kept in 37 °C for 1 hour. Chromogen (DAB substrate kit, 
ab94665, Abcam) was added to the slides for 10–13 minutes and then the slides were 
counterstained for 1.5 minutes with Mayers HTX (HistoLab, Gothenburg, Sweden). The slides 
were dehydrated in ethanol and xylene and then mounted in organic mounting media (Pertex, 
HistoLab, Gothenburg, Sweden). Positive tissues (testis) and negative control, where the 
primary antibody was replaced by goat serum, were included in the first runs to test the accuracy 
of the protocol. The immunohistochemistry procedure had to be run at three different occasions, 
resulting in a risk that the slides were not treated exactly the same way. To even out any errors, 
the slides were blinded by codes and randomly run in the procedure at the different occasions.  
 
Three representative samples from each ovary with good quality sections were chosen from the 
4-6 samples on every slide, and photographed in a microscope (Nikon Eclipse 80i, with 10x 
magnification objective). The micrographs were put together in Adobe Photoshop CS6 to three 
big photos per slide and the primary and secondary follicles were counted on the computer, 
blinded and by the same person. The immunostaining intensity of the AR in the secondary and 
antral follicles was evaluated blinded in the microscope according to the following grading: 
low, medium, high and very high. Each grading were based on the approximate amount of 
stained granulosa cells in the follicles, were low=0–30%, medium=30–60%, high=60–90% and 
very high=100% or slightly below 100%. Both early secondary follicles and vesicular 
secondary follicles (also called preantral in the literature) were evaluated, three of each if 
present. Three antral follicles, if present, were evaluated in each slide. The terminology of 
ovarian morphology was used according to Dixon et al. (2014), were primary follicles have a 
single layer cuboidal to columnar granulosa cells, early secondary follicles have ≥ 2 layers of 
granulosa cells and vesicular secondary follicles begin to have spaces between the granulosa 
cells but not a large single antrum. Antral (also called tertiary in the literature) follicles have 
continuous antrum between the granulosa cells.  
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Statistical analysis 
For statistical analyses of the effect of treatment on the number of primary and secondary 
follicles, general linear models (GLM procedure of SAS 9.3, Milltown, USA) were performed 
using the mean number of follicles (from three evaluated sections). The total numbers of 
follicles counted in the three sections were analysed using regression model with poisson 
distribution and adjustment for overdispersion by adding a Pearson scale parameter. Statistical 
analysis of the effect of treatment on ordinal variables (i.e. AR staining intensity on early 
secondary, vesicular secondary and antral follicles) was analysed using the genmod procedure 
of SAS with multinomial distribution and cumulative logit as function link. 
   
RESULTS 
In this study, no significant difference was found between the two different dosage regimes (0.5 
and 50 g BPA/kg/day) and the negative control group, regarding the staining intensity of the 
AR expression in the secondary and the antral follicles. The AR expression in the different 
follicles varied among individuals, but was not associated with BPA treatment (Table 1). 
Example of the AR staining intensity in the secondary follicles, where the AR is stained using 
immunohistochemistry, is presented in Figure 1. 
Table 1. AR staining intensity evaluated from low to very high in secondary and antral follicles in 
ovaries of BPA exposed rats (0.5 and 50 g BPA/kg/day) and negative control group (see section 
Immunohistochemistry in Material and methods for details). A median score of the staining intensity 
was calculated for every rat, from 3–6 follicles in every slide. The number of rats that were scored in 
each of the staining groups are presented 
  
Treatment groups 
 
Control 0.5 μg/kg/day 50 μg/kg/day 
Secondary follicles 
   
Low 4 3 3 
Medium 2 1 2 
High 4 2 2 
Very high 1 1 1 
Number of rats 11 8 8 
    
Antral follicles 
   
Low 9 4 5 
Medium 1 3 3 
High 1 0 0 
Very high 0 0 0 
Number of rats 11 7a 8 
a One of the slides lacked antral follicles 
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Figure 1. Ovarian expression of androgen receptor (AR) in vesicular secondary follicles. DAP was used 
to develop the immunohistochemistry and Mayers HTX was used for counterstaining. The staining 
intensity evaluated between very high to low (see section Immunohistochemistry in Material and 
methods for details). A. “Very high” in ovary of rat treated with 0.5 g BPA/kg/day. B. ”High” in ovary 
of rat treated with 50 g BPA/kg/day.  C. ”Medium” in ovary from rat in control group.   
 
No significant difference was found when comparing the number of primary and secondary 
follicles in the two dosage groups (0.5 and 50 g BPA/kg/day) to the negative control group 
(Figure 2).  
  
A B
 
C 
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Figure 2. Box plot demonstrating the number of follicles present in ovarian sections of the rats treated 
with 0.5 and 50 g BPA/kg/day and negative control.  Max, min and median values are shown and 
average is presented as a dot in the box. A. Number of primary follicles. B. Number of secondary 
follicles. 
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DISCUSSION 
In this study we investigated the ovaries of 52 weeks old rats that had been exposed to BPA in 
two low doses in utero and via lactation. No significant difference was found between BPA 
exposed rats compared to negative control, regarding the number of primary and secondary 
follicles and the expression of AR in the secondary and antral follicles.  
 
Unfortunately, a positive control group was not included in this study. As previously 
mentioned, vom Saal & Welshons (2006) discussed the importance of having a positive control 
when studying toxicology and since BPA is a weak oestrogen, DES or another strong oestrogen 
could have been chosen. The problem with that type of positive control is that BPA is even 
more complex and has more effects than just oestrogenic, for example anti-androgenic. But 
with a positive control, it would then have been possible to compare the strong oestrogen effects 
in the ovaries with BPA treated rats, to see if our assay is suitable for an oestrogenic chemical. 
Furthermore, it would then have been possible to compare our results to the positive control 
and if significantly different, we would know that BPA does not affect the number of follicles 
or the AR expression. Today, without a positive control, we cannot be sure that BPA does not 
affect the ovary, just that it did not in this study. A suggestion is, in a future BPA study of the 
ovaries, to include a positive control group.  
 
The expression of AR after BPA treatment has varied between studies. Santamaria et al. (2016) 
showed lower expression in primary, preantral (here called secondary) and antral follicles after 
treatment with 50 g BPA/kg/day, and a higher expression in primordial follicles and lower in 
primary follicles after 0.5 g BPA/kg/day. In this study, primordial and primary follicles were 
not evaluated in the magnification used in this study. Santamaria et al. (2016) quantified the 
expression using integrated optical density (IOD), were the images are converted into grey scale 
and the intensity of the grey is measured, which makes it possible to objectively differentiate 
small structures as well as larger. The possibility to use IOD in this study was unfortunately 
limited by the time available for a master thesis. Instead the intensity of staining was here 
evaluated using a 4-graded scale from low to very high, similarly to Rivera et al. (2015) who 
used a 5-graded scale. The problem with this type of evaluation method is the subjective 
judgement and possible bias. To minimize the bias, the evaluation of the staining in this study 
was made blinded and by one person. Rivera et al. (2015) only evaluated the expression in 
small antral follicles, presuming to be what in this thesis is called secondary follicles, but the 
stage is not defined in the article. They showed that AR expression was not increased in the 
small antral follicles in the BPA and DES treated groups, as it was in the negative control group, 
after injecting FSH to imitate the natural stimulation of the ovary. Rivera et al. (2011) got 
similar results as our study, with no effects on the AR expression in the ovaries from ewes 
treated with 50 g BPA/kg/day subcutaneously. However, contrary to our study, they presented 
a change in the numbers of follicles.  
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Rivera et al. (2011) reported results of fewer primordial follicles and an increase of primary 
follicles after BPA treatment. Santamaria et al., (2016) on the other hand reported a significant 
decrease of the number of primary follicles in both dosage groups, together with an increased 
number of CL in BPA treated animals. Similarly to Rivera et al. (2011) Rodríguez et al. (2010) 
found a decrease in primordial follicles and in contrast an increase in primary follicles 
compared to negative control. However, the results are from rats treated with a much higher 
BPA dose than previous reports (20 mg/kg/day). In the 50 g/kg/day group, no change in the 
number of follicles were reported. Likewise, no significant results could be presented in this 
study regarding the primary and the secondary follicles. In addition, in the initial study by 
Ekoutsidou (2017), no significance could be detected regarding the number of antral or atretic 
follicles or CL in treated rats compared to control. An important thing that separates the four 
studies from ours is the age of the animals when the ovaries were examined: at PND8 
(Rodríguez et al., 2010), PND30 (Rivera et al., 2011: Rivera et al., 2015), and at PND90 
(Santamaria et al., 2016), which all are much earlier than this study that was done at 52 weeks 
of age.  It is possible that the age of the ovaries affect the outcome of the result, or that the time 
that has passed since the rats were exposed have surpassed the effect of BPA. It is also possible 
that BPA has affected the primordial follicles, that were not counted here, that have been present 
in the ovary since neonatal stage and therefore were directly affected by the BPA. To be able 
to count the primordial follicles a special staining or other techniques may be used.  
 
Interestingly, when studying the AR expression, another important factor that separates our 
study from Santamaria et al. (2016) is the stage of the oestrus cycle that the rats were in at the 
time of the termination. In this study the rats were in dioestrus, characterised by low hormone 
levels, in contrary to Santamaria et al. (2016) where they were in oestrus and LH and FSH had 
recently stimulated the ovaries and ovulation had just occurred. It has previously been shown 
that FSH treatment increased the AR mRNA levels in the ovaries of primates (Weil et al. 1999) 
and declined in rat ovaries after both FSH and FSH+LH treatment (Tetsuka et al. 1995: see 
Tetsuka & Hillier, 1996). It is possible that the stimulation of FSH and/or LH differentiate the 
AR expression when the rats have been exposed to BPA and since the rats in this study lacked 
the stimulation, no alterations were found. When compared to the other studies presented, the 
ewes studied by Rivera et al. (2015) and Rivera et al. (2011) and the rats studied by Rodríguez 
et al. (2010) were all too young to have started the oestrus cycle. Rivera et al. (2011) and 
Rodríguez et al. (2010) did not show any alterations in the AR expression in ovaries that were 
not stimulated by FSH. Remarkably, this is contrary to what Rivera et al. (2015) found after 
stimulating the ovaries with FSH injections that reduced the AR expression in BPA exposed 
ewes. It would be interesting to study more of the AR expression in the different stages of the 
oestrus cycle and if the expression is altered with low dose BPA treatment in older rats.  
 
Ekoutsidou (2017) found in her master thesis that the ovaries had a significantly higher weight 
compared to control after the rats were exposed to BPA. The cause of this weight difference is 
still not explained. As mentioned, there was no significant difference in the number of follicles 
neither in this study nor by Ekoutsidou (2017). More continuous studies of these ovaries have 
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to be made. A suggestion is to include the end parts of the ovary, since only the middle piece 
of the ovaries were sectioned in this study, where the follicle morphology may be different i.e. 
including more slides for evaluation. Another idea is to measure the mass of the CL or the 
stroma of the ovary to investigate if those could be the reason for weight increase.  
 
The human fertility rates in the world are declining (Hamilton & Ventura, 2006: England & 
Azzopardi-Muscat, 2017) and it is important to investigate the cause. Studies made in fertility 
clinics have found an association with higher total urinary BPA concentration and poorer ovary 
response, with lower serum oestradiol and fewer oocytes retrieved, when undergoing in vitro 
fertilization (IVF). Also, reduced maturation of oocytes and fewer normally fertilized oocytes 
were associated with higher urinary BPA (Mok-Lin et al. 2009: Eichenlaub-Ritter & 
Pacchierotti, 2015). These reports suggest that BPA plays a role in the increasing infertility 
today, but more studies have to be done to find out how. The rats in this study were only exposed 
to BPA in the uterus and during lactation in order to investigate the developmental effects of 
BPA. It would also be interesting to design a study were the rats are continuously exposed to 
low doses of BPA for a longer time, like humans are, and then investigate the effects of BPA 
in the ovaries. It would also be interesting with a generation study, to directly investigate the 
effects of BPA on the fertility. Then the rats would also be exposed during the sensitive 
fertilization period and when the genome of the embryo starts to activate, which is in the two-
cell stage in rats (Zernicka-Goetz, 1994).  
 
Humans are exposed to many different chemicals today and BPA is just one of them. They may 
all interfere with the different systems in the body in different ways, and even if exposure to 
one single substance does not induce effects, a mixture of them might. There are studies of the 
so called “cocktail effect”, where scientists have used mixed exposures, for example Rajapakse 
et al. (2002) who studied the effect of the combination of 11 different xenoestrogenes, all below 
its non-observed effect-concentration, found an additive enhancement of the 17-oestradiol 
action. Manikkam et al. (2013) studied rat ovaries, after the rats had received a mixture of three 
endocrine disruptors used in plastics, including BPA, and found for example polycystic ovary 
syndrome and primordial follicle loss. It would be interesting to further study the cocktail effect, 
with low dose of BPA included, to see how the chemicals affect the ovaries and the AR 
expression when mixed. This will more reflect what humans are exposed to every day.  
 
It is possible that laboratory animals are exposed to a cocktail of chemicals and substances that 
influence the result, although the researchers are trying to avoid it. The ewes in the study by 
Rivera et al. (2011) and Rivera et al. (2015) were held at pasture, where phytoestrogens, which 
sheep are known sensitive to, may have added to the result of the BPA exposure. Likewise, in 
the study by Tyl et al. (2002) the authors were accused of using a feed with high amount of 
phytoestrogens and an insensitive rat model.  In this study, the rats were held in BPA-free cages, 
with a water bottle of glass and fed with low amount of phytoestrogens, to avoid background 
BPA, but the animals may have been exposed anyway. In a study by Churchwell et al. (2014) 
they found levels of BPA in the serum of the rats in the negative control group, which also were 
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held to avoid background BPA. The levels were comparable to the serum level of the lowest 
BPA dosage regimes in the study (2.5 g/kg/day) and the reason of the exposure could not be 
explained. Speculating, Beronius & Hanberg (2011) presented in their report different sources 
of exposure of BPA including tap water and indoor dust. Even though these levels are much 
lower than the food source, it could be a route of exposure to the rats as well. The results by 
Churchwell et al (2014) demonstrate the complexity of low-dose BPA-exposure studies where 
it is difficult to have a negative control to compare the results with, since the negative control 
also could be exposed to environmental BPA.  
 
Conclusion 
In summary, the results in this study suggest that low-dose BPA exposure during embryonic 
and foetal stage and neonatal period does not result in an alteration of the AR expression, nor 
in the number of primary and secondary follicles in 52 week old rats. However, BPA affected 
these ovaries causing an increased weight, (as presented in Ekoutsidou 2017), which still is 
unexplained. Since BPA is a chemical that is constantly present in our everyday life, more 
studies have to be made in order to further investigate the complexity of BPA and if low doses 
of BPA affect the ovary. 
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